Home    Back

 48. Primary antiphospholipid syndrome
 [ 3 clinical trials,    2 drugs（DrugBank: 1 drug),    0 target gene / 0 target pathway ] 

Searched query = "Primary antiphospholipid syndrome", "Primary antiphospholipid antibody syndrome"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement		Last_Refreshed_
on		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03540810August 15, 201811 June 2018Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid SyndromeHydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid SyndromePrimary Antiphospholipid SyndromeDrug: Hydroxychloroquine;Drug: PlaceboUniversity Hospital, AngersNot recruiting18 YearsN/AAll300Phase 3France
2NCT01956188May 201416 December 2017Omega 3 in LES and APSEfficacy of EPA and DHA Supplementation in Systemic Lupus Erythematosus and Primary Antiphospholipid SyndromeSystemic Lupus Erythematosus;Primary Antiphospholipid SyndromeDietary Supplement: EPA and DHA supplementation;Dietary Supplement: PlaceboUniversity of Sao PauloNot recruiting20 Years45 YearsFemale22N/ABrazil
3NCT04153201January 15, 201311 November 2019Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid SyndromeEffect of Hydroxychloroquine on Thrombosis Prevention and Antiphospholipid Antibody Levels in Patients With Primary Antiphospholipid Syndrome: An Pilot Randomized Prospective Study.Antiphospholipid SyndromeDrug: HydroxychloroquineNational and Kapodistrian University of AthensNot recruiting18 YearsN/AAll50N/AGreece